TCR2
A development stage company focusing on development of biological drugs and engineering T cells for cancer therapy.
Launch date
Employees
Market cap
€52.8m
Enterprise valuation
(€42m) (Public information from Jun 2023)
Share price
$1.48 TCRR
Cambridge Massachusetts (HQ)
Authorizing premium user...